Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Medifast, Inc. before investing.

In this article, we go over a few key elements for understanding Medifast, Inc.’s stock price such as:

• Medifast, Inc.’s current stock price and volume
• Why Medifast, Inc.’s stock price changed recently
• Upgrades and downgrades for MED from analysts
• MED’s stock price momentum as measured by its relative strength

About Medifast, Inc. (MED)

Before we jump into Medifast, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients’ long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body’s metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Want to learn more about Medifast, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Medifast, Inc..

Medifast, Inc.’s Stock Price as of Market Close

As of February 19, 2026, 4:00 PM, CST, Medifast, Inc.’s stock price was $10.620.

Medifast, Inc. is down 0.84% from its previous closing price of $10.710.

During the last market session, Medifast, Inc.’s stock traded between $10.100 and $10.660. Currently, there are approximately 10.99 million shares outstanding for Medifast, Inc..

Medifast, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Medifast, Inc. Stock Price History

Medifast, Inc.’s (MED) price is currently down 7.17% so far this month.

During the month of February, Medifast, Inc.’s stock price has reached a high of $11.910 and a low of $10.100.

Over the last year, Medifast, Inc. has hit prices as high as $15.480 and as low as $10.100. Year to date, Medifast, Inc.’s stock is down 0.56%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Medifast, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 19, 2026, there were 0 analysts who downgraded Medifast, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Medifast, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Medifast, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Medifast, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Medifast, Inc. (MED) by visiting AAII Stock Evaluator.

Relative Price Strength of Medifast, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 19, 2026, Medifast, Inc. has a weighted four-quarter relative price strength of -9.15%, which translates to a Momentum Score of 23 and is considered to be Weak.

Want to learn more about how Medifast, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Medifast, Inc. Stock Price: Bottom Line

As of February 19, 2026, Medifast, Inc.’s stock price is $10.620, which is down 0.84% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Medifast, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.